Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment
Changi General Hospital and Shimadzu (Asia Pacific) jointly launch centre to conduct mass spectrometry-based clinical testing and research for personalised treatment The Shimadzu-CGH Clinomics Centre (SC3) will improve turn-around time and clinical diagnostic accuracy of diseases such as hypertension and other endocrine conditions in adults SINGAPORE, 27 January 2021 – The Shimadzu-CGH Clinomics Centre (SC3),... Read more